Dr Ing (Germany) Today
P911 Stock | 57.98 0.84 1.47% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Dr Ing is trading at 57.98 as of the 24th of November 2024. This is a 1.47 percent increase since the beginning of the trading day. The stock's lowest day price was 56.2. Dr Ing has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Dr Ing hcF are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of October 2024 and ending today, the 24th of November 2024. Click here to learn more.
Moving together with P911 Stock
Moving against P911 Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
P911 Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Dr Ing's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Dr Ing or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman CEO | Oliver Blume |
Business Concentration | Auto Manufacturers, Consumer Cyclical (View all Sectors) |
Dr Ing hcF (P911) is traded on Frankfurt Exchange in Germany and employs 36,519 people. The company operates under Consumer Cyclical sector and is part of Auto Manufacturers industry.
Check Dr Ing Probability Of Bankruptcy
Ownership AllocationDr Ing hcF owns 7.0 % of its outstanding shares held by insiders and 13.64 % owned by institutions.
Check P911 Ownership Details
Dr Ing hcF Risk Profiles
Although Dr Ing's alpha and beta are two of the key measurements used to evaluate Dr Ing's performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 1.61 | |||
Standard Deviation | 2.09 | |||
Variance | 4.39 | |||
Risk Adjusted Performance | (0.09) |
P911 Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Dr Ing without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
All Next | Launch Module |
Dr Ing Corporate Management
Elected by the shareholders, the Dr Ing's board of directors comprises two types of representatives: Dr Ing inside directors who are chosen from within the company, and outside directors, selected externally and held independent of P911. The board's role is to monitor Dr Ing's management team and ensure that shareholders' interests are well served. Dr Ing's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dr Ing's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael Steiner | Member RD | Profile | |
Albrecht Reimold | Member Logistics | Profile | |
Detlev Platen | Head Board | Profile | |
Barbara Frenkel | Member Procurement | Profile | |
Andreas Haffner | Member Affairs | Profile |
Other Information on Investing in P911 Stock
Dr Ing financial ratios help investors to determine whether P911 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in P911 with respect to the benefits of owning Dr Ing security.